Response to "An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation".

Authors

Jamie George, Henry Ford Health
Nada Farhat, Henry Ford Health
Emily Thomas, Henry Ford HealthFollow

Recommended Citation

George J, Farhat N, and Thomas E. Response to "An approach to insulin tapering and discontinuation after glucagon-like peptide-1 receptor agonist initiation". Am J Health Syst Pharm 2022.

Document Type

Article

Publication Date

8-18-2022

Publication Title

American journal of health-system pharmacy

PubMed ID

35977884

ePublication

ePub ahead of print